D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

A brain abscess is a rare but life-threatening infection. Learn how advances in imaging, surgery, and diagnostics are ...

New study shows cheap HIV drug lamivudine helps diabetic macular edema, improving vision. Oral option could replace eye ...

Oozing crusts, painful pasterns, and persistent inflammations–mud fever is among the most common skin issues in horses.

To no great surprise, the U.K.’s health technology assessment body has found that the benefits of the first two approved Alzheimer’s disease drugs are too small to justify the costs. Neither Kisunla ...

Revuforj (revumenib) is an oral, first-in-class, selective menin inhibitor that is FDA approved for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene ...

Detailed price information for Soleno Therapeutics Inc (SLNO-Q) from The Globe and Mail including charting and trades.

TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer Kisunla, an early Alzheimer’s drug, marking a milestone in the country’s ...

There are two primary lymphoma types, each with its own distinct characteristics, treatment approaches, and prognosis.The most common is Non-Hodgkin Lymphoma (NHL), which accounts for around 90% ...

Dr. Fukaya shares tips for a patient-centered venous disease practice, challenges facing the vascular medicine field, where ...

Shanghai Yao Yuan Biotechnology Ltd., also known as Drug Farm, is advancing a portfolio of immune-modulating therapies for various indications including hepatitis B virus, hepatocellular cancer and a ...